Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
暂无分享，去创建一个
R. Greil | M. Gnant | H. Samonigg | G. Höfler | M. Filipits | F. Wrba | E. Heitzer | O. Dietze | S. Lax | N. Dandachi | R. Schaberl-Moser | F. Hofbauer | M. Artl | Bettina Weißenbacher | G. Böhm | M. Balić | Margit Resel | Ricarda Graf